Search
for
Sort by
Research 721–750 of 1000+
- A narrative review on cutaneous manifestations in polycystic ovary syndrome: pathophysiology, diagnosis, management, and psychosocial impact
- A systematic review and meta-analysis on the effects of the ultra-pulse CO2 fractional laser in the treatment of depressed acne scars
- A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome
- Efficacy and Pain Tolerance of Alexandrite Laser Hair Removal at Different Stages of the Menstrual Cycle
- Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot study
- Sinapic acid and glabridin synergistically mitigate androgenetic alopecia by modulating ferroptosis through stabilization of β-catenin against ubiquitin-dependent degradation.
- A Complex Clinical Situation in Polycystic Ovary Syndrome: HAIR‐AN Syndrome ‘‘Case Report’’
- Dermatological care of gender‐diverse patients in Australia
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers
- Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- Where Have the Periods Gone? The Evaluation and Management of Functional Hypothalamic Amenorrhea
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Cyanidin 3-O-arabinoside suppresses DHT-induced dermal papilla cell senescence by modulating p38-dependent ER-mitochondria contacts
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
- Incredible Combination of Lifestyle Modification and Herbal Remedies for Polycystic Ovarian Syndrome Management
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- The effect of gonadoliberin analog treatment in precocious puberty on polycystic ovarian syndrome prevalence in adulthood
- Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?
- Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review
- Pattern of body fat distribution in patients of PCOS using DEXA-based indices
- Effects of Allium hookeri Extracts on Hair-Inductive and Anti-Oxidative Properties in Human Dermal Papilla Cells
- The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population
- Inflammatory and Anti-Inflammatory Parameters in PCOS Patients Depending on Body Mass Index: A Case-Control Study
- The investigation and management of hirsutism
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells
- Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?